European Medicines Agency - Regulatory - Regulation of medicines

6 -Public Involvement



    Description

Name

 

ECAPN - European Child & Adolescent Psychopharmacology Network

Involvement of patients, parents or their organisations in the protocol design Yes Parent association are regularly involved in designing and implementing Academic trials; they are consulted by members also for industrial trials (Autism Europe, ADHD Europe, others) HyperSupers – TDAH, France, AIFA.Italy, ADDIS UK); see attached document "Autisme Europe letter" as an example. Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network) in order to define future formal collaborations.
Involvement of patients, parents or their organisations in creating the protocol info package Yes arent associations are regularly involved in preparing protocol information packages for Academic studies; they are also locally consulted for Industrial clinical trials. ( see above). Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network) in order to define future formal collaborations.
Involvement of patients, parents or their organisations in prioritisation of needs for Clinical Trials Yes Parent Associations are periodically consulted in order to prioritize the needs for clinical trials in children ( See Above). Contacts have been also established with KIDS Barcelona (http://www.icanresearch.org/barcelona/; member of the iCAN network) in order to define future formal collaborations.